However, patients with MM often bear immune dysfunction with poor NK cell cytotoxic functions due to an increased expression of CD57+ (terminally differentiated marker), killing inhibitor receptors, and reduced expression of activating receptors [22]. Here, B3GAT1 is linked to Miyoshi myopathy.